Desloratadine inhibits human skin mast cell activation and histamine release

Journal of Investigative Dermatology

Volumn 129, Issue 11, 2009, Pages 2723-2726

  Weller, Karsten ^a   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; CALCIUM IONOPHORE; CETIRIZINE; DESLORATADINE; LORATADINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1;

CELL ACTIVATION; CONCENTRATION RESPONSE; DRUG MEGADOSE; FLUORESCENCE ACTIVATED CELL SORTING; HISTAMINE RELEASE; HUMAN; IN VITRO STUDY; LETTER; MAST CELL; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SKIN CELL; SKIN MAST CELL;

HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HISTAMINE RELEASE; HUMANS; LORATADINE; MAST CELLS; SKIN;

EID: 70350068543     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.134     Document Type: Letter

References (11)

1. Baena-Cagnani CE (2001) Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. Allergy 56(Suppl 65):21-27
2. Frossard N, Strolin-Benedetti M, Purohit A, Pauli G (2008) Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Clin Pharmacol 65:172-179
3. Genovese A, Patella V, De Crescenzo G, De Paulis A, Spadaro G, Marone G (1997) Loratadine and desethoxylcarbonyl-lorata-dine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. Clin Exp Allergy 27:559-567
4. Grützkau A, Smorodchenko A, Lippert U, Kirchhof L, Artuc M, Henz BM (2004) LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A 61:62-68
5. Kowalski ML, Lewandowska A, Wozniak J, Makowska J, Jankowski A, DuBuske L (2005) Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine. Allergy 60:80-85
6. Lippert U, Möller A, Welker P, Artuc M, Henz BM (2000) Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1-and H2-receptor antagonists. Exp Der-matol 9:118-124
7. Metz M, Maurer M (2007) Mast cells-key effector cells in immune responses. Trends Immunol 28:234-241
8. Metz M, Siebenhaar F, Maurer M (2008) Mast cell functions in the innate skin immune system. Immunobiology 213: 251-260
9. Młynek A, Maurer M, Zalewska A (2008) Update on chronic urticaria: focusing on mechanisms. Curr Opin Allergy Clin Immunol 8:433-437
10. Wang YH, Taché Y, Harris AG, Kreutner W, Daly AF, Wei JY (2005) Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique. Allergy 60:117-124
11. Zhao Y, Leung PC, Woo KS, Chen GG, Wong YO, Liu SX et al. (2004) Inhibitory effects of budesonide, desloratadine and dexametha-sone on cytokine release from human mast cell line (HMC-1). Inflamm Res 53:664-669